Legacy Bridge’s iShares Biotechnology ETF IBB Stock Holding History

Legacy Bridge’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-57	Closed	-$6K	–	290
2019 Q2	$6K	Hold	57	–	–	0.01%	288
2019 Q1	$6K	Buy	+57	New	+$6.25K	0.01%	293

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Legacy Bridge's IBB Position: Q3 2019 in Review

Legacy Bridge sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 57 shares — an estimated $6K sold.

Legacy Bridge first reported a position in IBB in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q2 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Legacy Bridge reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Legacy Bridge sold 57 iShares Biotechnology ETF shares in Q3 2019, an estimated $6K.
Legacy Bridge first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 2 quarters.
Legacy Bridge's iShares Biotechnology ETF position peaked at $6K in Q2 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Legacy Bridge's 13F filing for Q3 2019, filed 15 Oct 2019.